Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers	human papillomavirus-related penile squamous cell carcinoma, neoplasm	Active, not recruiting	Phase 1 / Phase 2	2026-02-05		NCT03260023

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
EMD Serono Research & Development Institute, Inc.	18
Merck KGaA, Darmstadt, Germany	31
Pfizer	431
Transgene	3

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Léon Bérard	Lyon	France	71
Centre Paul Strauss - ICANS - Institut de cancérologie Strasbourg Europe	Strasbourg	France	1
CHU Besançon	Besançon	France	32
CLCC Georges-François Leclerc	Dijon	France	3
Fundación de Investigación biomédica H. 12 de Octubre	Madrid	Spain	1
Fundación de Investigación Biomédica Hospital Clínico San Carlos	Madrid	Spain	1
Hopital de la Timone	Marseille	France	14
Hospital General de Valencia	Valencia	Spain	4
Hospital Virgen de la Victoria	Málaga	Spain	8
Hospital Virgen de las Nieves	Granada	Spain	5
Hôpital Saint André - CHU de Bordeaux	Bordeaux	France	1
Hôpitaux Civils de Colmar - Hôpital Pasteur	Colmar	France	1
I.C.O. Gauducheau	Saint-Herblain	France	1
I.C.O. Paul Papin	Angers	France	1
ICO Badalona - Hospital Germans Trias i Pujol	Badalona	Spain	2
Institut Claudius Regaud - IUCT - Oncopole	Toulouse	France	1
Institut Curie	Paris	France	44
Institut Gustave Roussy	Villejuif	France	58
Mayo Clinic	Rochester	United States	664
Mayo Clinic	Jacksonville	United States	122

Clinical trials